EXAMINE THIS REPORT ON DOXEPIN

glycerol phenylbutyrate will lessen the level or effect of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Glycerol phenylbutyrate is actually a weak inducer of CYP3A4. Check for decreased efficacy of CYP3A4 substrates which have a slender therapeutic index.Stay away from concomitant use of tucatinib with CYP3